Skip to main content
. 2013 Feb;182(2):540–552. doi: 10.1016/j.ajpath.2012.10.021

Figure 3.

Figure 3

Survival analysis of 104 patients with glioblastoma either expressing or not expressing HLA-G protein at the tumor site (Kaplan-Meier survival curves). A: Survival time of 104 patients from the date of craniotomy. The median survival rate is 8 months for HLA-G–positive and HLA-G–negative patients. B: Survival time of 23 patients after 15 months from the date of craniotomy. HLA-G–negative patients are still alive 7 months longer than HLA-G–positive patients (P = 0.04).